Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MAP Pharmaceuticals, Inc. | 0 | reported | 01 Mar 2013 | tx 338+510,211−752,478.05 |
| MyoKardia Inc | 0 | reported | 17 Nov 2020 | tx 218+4,074,497−5,101,937 |
| LianBio | 0 | reported | 15 Feb 2024 | tx 7+145,448−92,066 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Feb 2024 | TAX_WITHHOLDING | LianBio | 19,218 | 4.76 USD | |
| 15 Feb 2024 | EXERCISE | LianBio | 36,300 | 2.52 USD | |
| 15 Feb 2024 | EXERCISE | LianBio | 36,300 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | LianBio | 36,300 | 0.00 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | LianBio | 36,300 | 0.00 USD | deriv |
| 29 Dec 2021 | EXERCISE | LianBio | 36,548 | 6.49 USD | |
| 29 Dec 2021 | EXERCISE | LianBio | 36,548 | 0.00 USD | deriv |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 7,000 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 10,000 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 53,087 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 53,087 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 53,087 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 141,405 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 129,407 | — | |
| 17 Nov 2020 | TENDER | MyoKardia Inc | 300,000 | — | |
| 17 Nov 2020 | OTHER | MyoKardia Inc | 72,562 | — | deriv |
| 17 Nov 2020 | OTHER | MyoKardia Inc | 303,500 | — | deriv |
| 17 Nov 2020 | OTHER | MyoKardia Inc | 184,100 | — | deriv |
| 17 Nov 2020 | OTHER | MyoKardia Inc | 236,500 | — | deriv |
| 17 Nov 2020 | OTHER | MyoKardia Inc | 142,733 | — | deriv |
| 17 Nov 2020 | OTHER | MyoKardia Inc | 149,517 | — | deriv |
| 02 Jul 2020 | SALE | MyoKardia Inc | 1,776 | 93.55 USD | |
| 02 Jul 2020 | SALE | MyoKardia Inc | 3,224 | 94.22 USD | |
| 02 Jun 2020 | SALE | MyoKardia Inc | 800 | 101.72 USD | |
| 02 Jun 2020 | SALE | MyoKardia Inc | 600 | 100.60 USD |
1 purchase reported after at least 12 months of silence — most recent on 04 Jan 2019.